Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.

Pharmacogenetics - 1 Feb 2000

Makoff A J, Graham J M, Arranz M J, Forsyth J, Li T, Aitchison K J, Shaikh S, Grünewald R A

Abstract excerpt

Some patients with idiopathic Parkinson's disease experience hallucinations as a result of treatment with levodopa and dopamine agonists. There is evidence for some heterogeneity in these hallucinating patients based on duration of Parkinson's disease at onset of hallucinations. We compared the frequency of polymorphisms in the dopamine D2 and D3 receptor genes between patients with drug-induced hallucinations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Dopamine Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hallucinations

Share to Levodopa

Share to Odds Ratio

Share to Parkinson Disease

Share to Receptors, Dopamine D2

Share to Receptors, Dopamine D3

Source

Identifiers

PMID: 10739171
DOI: 10.1097/00008571-200002000-00006

Genes

DRD2
DRD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.PMID 10739171Read ↗

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.Semantic proximity Read ↗

Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.Semantic proximity Read ↗

Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.Semantic proximity Read ↗

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.Semantic proximity Read ↗

A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms.Semantic proximity Read ↗

Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".Semantic proximity Read ↗

The role of genetic factors in the occurrence of levodopa-induced motor complications in Parkinson's disease.Semantic proximity Read ↗

The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.Semantic proximity Read ↗

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.Semantic proximity Read ↗

<scp>l</scp>-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphismSemantic proximity Read ↗

Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approach.Semantic proximity Read ↗

Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.